Abstract
Adherence to the rules for antithrombotic ment in atrial fibrillation patients significantly reduces the risk of stroke. We review the criteria for the use of anti-vitamin K as well as its daily management in patients with atrial fibrillation.
MeSH terms
-
Atrial Fibrillation / complications*
-
Fibrinolytic Agents / therapeutic use*
-
Guideline Adherence*
-
Humans
-
Stroke / etiology*
-
Stroke / prevention & control*
-
Vitamin K / antagonists & inhibitors
Substances
-
Fibrinolytic Agents
-
Vitamin K